Russo A - Search Results

1

EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment.

Friedlaender A, Subbiah V, Russo A, Banna GL, Malapelle U, Rolfo C, Addeo A. Friedlaender A, et al. Among authors: russo a. Nat Rev Clin Oncol. 2022 Jan;19(1):51-69. doi: 10.1038/s41571-021-00558-1. Epub 2021 Sep 24. Nat Rev Clin Oncol. 2022. PMID: 34561632 Review.

2

NSCLC and HER2: between lights and shadows.

Ricciardi GR, Russo A, Franchina T, Ferraro G, Zanghì M, Picone A, Scimone A, Adamo V. Ricciardi GR, et al. Among authors: russo a. J Thorac Oncol. 2014 Dec;9(12):1750-62. doi: 10.1097/JTO.0000000000000379. J Thorac Oncol. 2014. PMID: 25247338 Free article. Review.

3

Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance.

Russo A, Franchina T, Ricciardi GR, Ferraro G, Scimone A, Bronte G, Russo A, Rolfo C, Adamo V. Russo A, et al. Expert Rev Anticancer Ther. 2016 Jun;16(6):615-23. doi: 10.1080/14737140.2016.1182427. Epub 2016 May 10. Expert Rev Anticancer Ther. 2016. PMID: 27109446 Review.

4

Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation.

Russo A, Franchina T, Ricciardi GRR, Adamo V. Russo A, et al. J Thorac Oncol. 2017 Jan;12(1):e6-e8. doi: 10.1016/j.jtho.2016.09.132. J Thorac Oncol. 2017. PMID: 27988103 Free article. No abstract available.

5

Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study.

Singhal S, Rolfo C, Maksymiuk AW, Tappia PS, Sitar DS, Russo A, Akhtar PS, Khatun N, Rahnuma P, Rashiduzzaman A, Ahmed Bux R, Huang G, Ramjiawan B. Singhal S, et al. Among authors: russo a. Cancers (Basel). 2019 Jul 29;11(8):1069. doi: 10.3390/cancers11081069. Cancers (Basel). 2019. PMID: 31362354 Free PMC article.

6

How I treat ALK-positive non-small cell lung cancer.

McCusker MG, Russo A, Scilla KA, Mehra R, Rolfo C. McCusker MG, et al. Among authors: russo a. ESMO Open. 2019 Jul 20;4(Suppl 2):e000524. doi: 10.1136/esmoopen-2019-000524. eCollection 2019. ESMO Open. 2019. PMID: 31423342 Free PMC article. Review.

7

Liquid biopsy tracking of lung tumor evolutions over time.

Russo A, De Miguel Perez D, Gunasekaran M, Scilla K, Lapidus R, Cooper B, Mehra R, Adamo V, Malapelle U, Rolfo C. Russo A, et al. Expert Rev Mol Diagn. 2019 Dec;19(12):1099-1108. doi: 10.1080/14737159.2020.1680287. Epub 2019 Oct 16. Expert Rev Mol Diagn. 2019. PMID: 31608732 Review.

8

Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma.

de Miguel-Pérez D, Bayarri-Lara CI, Ortega FG, Russo A, Moyano Rodriguez MJ, Alvarez-Cubero MJ, Maza Serrano E, Lorente JA, Rolfo C, Serrano MJ. de Miguel-Pérez D, et al. Among authors: russo a. Cancers (Basel). 2019 Nov 7;11(11):1750. doi: 10.3390/cancers11111750. Cancers (Basel). 2019. PMID: 31703465 Free PMC article.

9

RET fusions in solid tumors.

Li AY, McCusker MG, Russo A, Scilla KA, Gittens A, Arensmeyer K, Mehra R, Adamo V, Rolfo C. Li AY, et al. Among authors: russo a. Cancer Treat Rev. 2019 Dec;81:101911. doi: 10.1016/j.ctrv.2019.101911. Epub 2019 Oct 30. Cancer Treat Rev. 2019. PMID: 31715421 Review.

10

Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies.

Zhang P, Xiong X, Rolfo C, Du X, Zhang Y, Yang H, Russo A, Devenport M, Zhou P, Liu Y, Zheng P. Zhang P, et al. Among authors: russo a. Cancers (Basel). 2020 Jan 24;12(2):284. doi: 10.3390/cancers12020284. Cancers (Basel). 2020. PMID: 31991588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,450 results

Search Page